U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News National Cancer Institute (NCI) <http://www.cancer.gov/> FOR IMMEDIATE RELEASE: Friday, October 20, 2006 CONTACT: NCI Media Relations Branch, 301-496-6641, <ncipressofficers@xxxxxxxxxxxx> News Advisory Note To Reporters and Editors: NATIONAL CANCER INSTITUTE HOSTS SESSION ON NEW DEVELOPMENTS IN NANOTECHNOLOGY WHAT: Please join us to discuss new developments in nanotechnology in cancer. The session will include a review of nanotechnology, how it is affecting research, and accelerating the development of new diagnostics and therapies. Speakers will include NCI leadership, as well as biologists, engineers and physicians who are members of the NCI Alliance for Nanotechnology in Cancer, an initiative to accelerate the application of nanotechnology to cancer research and patient care. Among the featured speakers will be scientists discussing their work in delivery, imaging and therapeutics. WHO: -- ANNA D. BARKER, PH.D. (NCI): NCI Alliance for Nanotechnology in Cancer: Catalyst for Transformation -- THOMAS A. KALIL (UNIVERSITY OF CALIFORNIA, BERKELEY): Nanotechnology Policy Development: Regional and National Initiatives -- SANJIV GAMBHIR, M.D., PH.D. (STANFORD UNIVERSITY): Molecular Imaging in Living Subjects: Shining a New Light on Cancer Diagnostics -- SADIK ESENER, PH.D. (UNIVERSITY OF CALIFORNIA, SAN DIEGO): Multi-compartment Delivery Vehicles: Novel Approaches for Targeted Therapies -- JAMES HEATH, PH.D. (CALIFORNIA INSTITUTE OF TECHNOLOGY): Detecting the Impossible: Cancer Candidate Biomarkers and Capture Agents -- SCOTT MCNEIL, PH.D. (NCI): Preclinical Characterization of Nanoparticles Intended for Medical Applications WHEN: WEDNESDAY, OCTOBER 25, 2006: 12:15-1:30 P.M. PDT WHERE: Marina del Rey Room, San Diego Marriott La Jolla 4240 La Jolla Village Drive La Jolla, California 92037 Directions and map: <http://marriott.com/property/mapandnearbyairports/default.mi?marshaCode =sanlj> If you cannot attend in person, the audio portion of the media session is available to reporters via a toll-free conference line at 866-755-5928, conference ID #9241089. Slides presented during the session can be viewed live, on-line at <http://nihbreeze.cit.nih.gov/nanomedia/>. To access the slides, use the "enter as guest" option. The session will begin promptly at 12:15 p.m. PDT. Reporters should dial in and log on 5-10 minutes before the start of the conference. Following the presentations, an operator will inform callers that the session is open to questions. To ask a question, press "*1" on your touchtone phone. You will hear a tone to indicate your question is pending. For more information on the NCI Alliance for Nanotechnology in Cancer, please visit <http://nano.cancer.gov>. For more information about cancer, please visit the NCI Web site at <http://www.cancer.gov> or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). The National Institutes of Health (NIH) -- "The Nation's Medical Research Agency" -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <http://www.nih.gov>. ## This NIH News Release is available online at: http://www.nih.gov/news/pr/oct2006/nci-20.htm. To subscribe (or unsubscribe) from this list, go to http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.
